Earnings Summary

Agilon Health, Inc.’s revenue jumped 41.21% since last year same period to $1604.35Mn in the Q1 2024. On a quarterly growth basis, Agilon Health, Inc. has generated 51.92% jump in its revenue since last 3-months.

Agilon Health, Inc.’s net profit fell -83.15% since last year same period to $2.7Mn in the Q1 2024. On a quarterly growth basis, Agilon Health, Inc. has generated 101.48% jump in its net profits since last 3-months.

Agilon Health, Inc.’s net profit margin fell -88.07% since last year same period to 0.17% in the Q1 2024. On a quarterly growth basis, Agilon Health, Inc. has generated 100.97% jump in its net profit margins since last 3-months.

Agilon Health, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.08 - a -700% fall from last quarter’s estimates.

Agilon Health, Inc.’s earning per share (EPS) estimates for the current year stand at -0.08.

Agilon Health, Inc.’s earning per share (EPS) fell -125% since last year same period to -0.01 in the Q1 2024. This indicates that the Agilon Health, Inc. has generated -125% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Agilon Health, Inc.’s return on assets (ROA) stands at -0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Agilon Health, Inc.’s return on equity (ROE) stands at -0.23.